HW de Valk, JD Banga, JWJ Wester, CB … - Annals of internal medicine, 1995 - Am Coll Physicians Objective: To compare the efficacy and safety of two subcutaneous doses of
danaparoid with that of continuous intravenous administration of unfractionated
heparin in the treatment of venous thromboembolism. Cited by 71 - Related articles - BL Direct - All 5 versions
M Danhof, A De Boer, HN Magnani, JCJ … - Pathophysiology of Haemostasis and Thrombosis, 1992 - content.karger.com Pharmacokinetic investigations on Orgaran (Org 10172) have been conducted by
monitoring the following biological effects: plasma anti-Xa, anti-IIa and
Ila-generation-inhibiting (IlaGI) activities. In addition, a limited number ... Cited by 45 - Related articles - All 5 versions
MT Nurmohamed, J Fareed, D Hoppensteadt, … - Seminars in thrombosis and hemostasis, 1991 - cat.inist.fr Pharmacological and linical studies wiht lomoparan, a low molecular weight
glycosaminoglycan. MT NURMOHAMED, J FAREED, D HOPPENSTEADT ... Cited by 12 - Related articles - All 2 versions
CP Henny, H Ten Cate, JW Ten Cate, S … - Lancet, 1983 - ncbi.nlm.nih.gov Org 10172, a new, natural heparinoid, was used as the sole anticoagulant in
twelve patients with acute or acute-on-chronic renal failure, who underwent
haemodialysis 55 times. All patients had either intercurrent bleeding or a ... Cited by 30 - Related articles - All 4 versions
[CITATION] for the Recurrence Of Clot In This Pregnancy (ROCIT) Study Group. Safety of withholding …
SD Chunilal, E Young, MA Johnston, C … - Thrombosis and haemostasis, 2002 - ncbi.nlm.nih.gov Pregnancy is associated with a physiological increase in coagulation factors and
heparin binding proteins; both can affect the activated partial thromboplastin
time (APTT) in response to unfractionated heparin (UFH) invalidating the ... Cited by 21 - Related articles - BL Direct - All 3 versions
M De Swiet, E Floyd, E Letsky - British journal of hospital medicine, 1987 - ncbi.nlm.nih.gov 1: Br J Hosp Med. 1987 Sep;38(3):264. Low risk of recurrent thromboembolism
in pregnancy. de Swiet M, Floyd E, Letsky E. Publication ... Cited by 38 - Related articles
R McKenna, ER Cole, U Vasan - The Journal of pediatrics, 1983 - Elsevier Clinical and laboratory observations Is warfarin sodium contraindicated in the
lactating mother? Rajalaxmi McKenna, MD, Edmond R. Cole, Ph.D., and Ushanalini
Vasan, MD Chicago, IlL LACTATING MOTHERS taking warfarin sodium are advised ... Cited by 92 - Related articles - All 5 versions
- ►hematologylibrary.org - Free from Publisher SG Shaughnessy, J Hirsh, M Bhandari, JM … - Blood, 1999 - bloodjournal.hematologylibrary.org Although it is well established that long-term heparin therapy causes
osteoporosis, it is unknown whether heparin-induced bone loss is reversible when
heparin treatment is stopped. To address this question, we randomized rats ... Cited by 46 - Related articles - BL Direct - All 4 versions
M Monreal, E Lafoz, A Olive, L Del Rio, C … - Thrombosis and haemostasis, 1994 - ncbi.nlm.nih.gov 1: Thromb Haemost. 1994 Jan;71(1):7-11. Comparison of subcutaneous unfractionated
heparin with a low molecular weight heparin (Fragmin ... Cited by 301 - Related articles - BL Direct - All 2 versions
